Emery Howard Portfolio Management’s iShares Biotechnology ETF IBB Stock Holding History

Emery Howard Portfolio Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$410K	Buy	2,684 +2	+0.1%	+$310	0.05%	38
2021 Q3	$434K	Buy	2,682 +291	+12%	+$49K	0.06%	37
2021 Q2	$391K	Sell	2,391 -53	-2%	-$8.16K	0.06%	36
2021 Q1	$368K	Buy	2,444 +963	+65%	+$153K	0.06%	35
2020 Q4	$224K	Sell	1,481 -20	-1%	-$2.86K	0.04%	36
2020 Q3	$203K	Hold	1,501	–	–	0.04%	33
2020 Q2	$205K	Buy	+1,501	New	+$191K	0.04%	31
2016 Q1	–	Sell	-1,779	Closed	-$201K	–	31
2015 Q4	$201K	Buy	+1,779	New	+$193K	0.05%	31
2015 Q3	–	Sell	-1,779	Closed	-$219K	–	31
2015 Q2	$219K	Hold	1,779	–	–	0.06%	30
2015 Q1	$204K	Buy	+1,779	New	+$196K	0.05%	31

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Emery Howard Portfolio Management's IBB Position: Q4 2021 in Review

Emery Howard Portfolio Management increased its iShares Biotechnology ETF (IBB) stake by 0.07% in Q4 2021, buying an estimated $310 and bringing the position to 2,684 shares worth $410K. The position accounts for 0.05% of the portfolio, ranked #38.

Emery Howard Portfolio Management first reported a position in IBB in Q1 2015 and has held it in 10 quarters since. The position peaked at $434K in Q3 2021. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

Emery Howard Portfolio Management held 2,684 shares of iShares Biotechnology ETF worth $410K as of Q4 2021.
Emery Howard Portfolio Management bought 2 iShares Biotechnology ETF shares in Q4 2021, an estimated $310.
iShares Biotechnology ETF made up 0.05% of Emery Howard Portfolio Management's portfolio in Q4 2021, its #38 holding.
Emery Howard Portfolio Management first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 10 quarters since.
Emery Howard Portfolio Management's iShares Biotechnology ETF position peaked at $434K in Q3 2021.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Emery Howard Portfolio Management's 13F filing for Q4 2021, filed 6 Jan 2022.